Can Artificial Intelligence Lead to Personalized Macular Edema Treatment?

Using automated spectral-domain optical coherence tomography, researchers found the presence of subretinal fluid (SRF) in individuals with diabetic macular edema (DME) is associated with lower baseline best-corrected visual acuity. The findings of this retrospective study suggest automated quantification of intraretinal fluid and SRF may be an objective approach to assess DME treatment. Using automated spectral-domain optical coherence tomography (OCT), researchers found the presence of subretinal fluid (SRF) in individuals with diabetic macular edema (DME) is associated with lower baseline best-corrected visual acuity (BCVA). However, the results, published in JAMA Ophthalmology, also show SRF is associated with good response to anti-vascular endothelial growth factor (VEGF) therapy. The findings of the retrospective study suggest automated quantification of intraretinal fluid (IRF) and SRF may be an objective approach to assess DME treatment.